Bertek and UDL Laboratories Digitek® Tablets Recall for Digitalis Toxicity
Actavis Totowa Recalls All Lots of Digitek
On April 8, 2008, the FDA announced a nationwide recall of all lots of Bertek and UDL Laboratories Digitek® Tablets manufactured and distributed by generic drug-maker Actavis and Mylan Pharmaceuticals. Digitek® is a generic brand of the drug digoxin, used to treat abnormal heart rhythms and congestive heart failure. As a result of manufacturing defects, these tablets may contain up to twice the labeled dose of the drug. If ingested, the unsafe dosages of digoxin could pose a serious risk and lead to a deadly illness called digitalis toxicity. This condition is particularly hazardous to patients with severe kidney problems. The recall may involve Digitek® Tablets manufactured as early as 2006.
Digitalis Toxicity
Digitalis toxicity is a potentially lethal illness that is common among people with kidney troubles, especially those with renal failure. Symptoms of digitalis toxicity include nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, heart palpations, and bradycardia (slower than normal heartbeat rate). Vision changes such as seeing lights and bright colors, experiencing changes in color perception, and blurred vision can also occur. Consumers also experience decreased urine output and excessive nighttime urination, decreased consciousness, overall swelling, and difficulty breathing while lying down.
Questions and Consultations
If you or someone you love has been taking a form of Digitek or experienced any of the symptoms related to digitalis toxicity, and you would like to discuss your rights, please complete our brief evaluation form. A member of Seeger Weiss LLP's experienced staff will call you to discuss your potential claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in New York, New Jersey, Pennsylvania, Oklahoma, and California, and its attorneys practice in courts throughout the country.
